Roche to acquire TIB Molbiol to expand PCR-testing portfolio
The acquisition will enable Roche to further expand the portfolio with more than 45 CE-IVD assays and more…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
13 Sep 21
The acquisition will enable Roche to further expand the portfolio with more than 45 CE-IVD assays and more…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
09 Sep 21
Exscientia will leverage its AI-driven platform and in-house drug expertise to discover and develop five phase 1-ready drug…
08 Sep 21
Masterflex Bioprocessing provides peristaltic and single-use bioprocessing solutions and aseptic single-use fluid transfer technologies
08 Sep 21
Moderna has agreed to license the mRNA-3351 to ILCM free of cost, involving no upfront fees, and any…
07 Sep 21
Hetero will manufacture the drug at its facility in Hyderabad and commercialise it in India by the end…
07 Sep 21
EMA’s human medicines committee (CHMP) is expected to undertake an accelerated assessment of data submitted by Pfizer and…
06 Sep 21
AstraZeneca will deliver 60 million doses by the end of Q3 2021, 75 million doses by the end…
06 Sep 21
Biological E developed Corbevax in partnership with Baylor College of Medicine and biopharmaceutical company Dynavax Technologies
03 Sep 21
The transaction will advance Baxter and Hillrom’s expansion into digital and connected care solutions that enable hospital-level care…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
03 Sep 21
Fujifilm Toyama Chemical’s radiopharmaceutical business will be succeeded by a new entity, formed through an absorption-type split